2017
DOI: 10.1038/s41598-017-02123-2
|View full text |Cite
|
Sign up to set email alerts
|

A One-Pot Three-Component Double-Click Method for Synthesis of [67Cu]-Labeled Biomolecular Radiotherapeutics

Abstract: A one-pot three-component double-click process for preparing tumor-targeting agents for cancer radiotherapy is described here. By utilizing DOTA (or NOTA) containing tetrazines and the TCO-substituted aldehyde, the two click reactions, the tetrazine ligation (an inverse electron-demand Diels-Alder cycloaddition) and the RIKEN click (a rapid 6π-azaelectrocyclization), could simultaneously proceed under mild conditions to afford covalent attachment of the metal chelator DOTA or NOTA to biomolecules such as to al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 42 publications
1
15
0
Order By: Relevance
“…Apart from this, great effort has been put into the development of additional radiolabeled tetrazines as potential pretargeting imaging agents. However, many reports of these new radiolabeled tetrazines lack in vivo evaluation of their use as pretargeted imaging agents, likely due to the lack of alternative pretargeting screening models to mAbs [29][30][31][32][33][34]. Although TCO-CC49 mAb serves as a positive control for pretargeting experiments because of its extensive optimization and evaluation, antibodies as a screening model is challenged by the need of meticulous pretargeting procedures, disease models to test them, and the fact that they and their TCO modification can be expensive to produce.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from this, great effort has been put into the development of additional radiolabeled tetrazines as potential pretargeting imaging agents. However, many reports of these new radiolabeled tetrazines lack in vivo evaluation of their use as pretargeted imaging agents, likely due to the lack of alternative pretargeting screening models to mAbs [29][30][31][32][33][34]. Although TCO-CC49 mAb serves as a positive control for pretargeting experiments because of its extensive optimization and evaluation, antibodies as a screening model is challenged by the need of meticulous pretargeting procedures, disease models to test them, and the fact that they and their TCO modification can be expensive to produce.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, tetrazine ligations – the fastest bioorthogonal reactions described so far – have had a significant impact by enabling strategies for (i) rapid radiolabeling using prosthetic groups, (ii) site‐specific radiolabeling, and (iii) pretargeting approaches based on in vivo chemistry . To this end, various radiolabeled 1,2,4,5‐tetrazines (Tz) have been developed as clickable tools for PET and SPECT imaging ( 18 F, 11 C, 111 In, 64 Cu, 123 I, 125 I), and targeted radiotherapy ( 177 Lu, 67 Cu) making use of the fast bioorthogonal ligation with trans ‐cyclooctenes (TCO).…”
Section: Figurementioning
confidence: 99%
“…Examples of these include ligands 55 , 56 and 60 for rapid conjugation to specific peptides by Cu I ‐catalysed click reaction, and strained cyclooctynes 57 – 59 for copper‐free attachment to azide‐functionalised peptides, proteins and nanoparticles. Also, tetrazine‐bearing NOTA derivatives 61 and 62 have been used for linking trans ‐cyclooctene‐functionalised antibodies using inverse‐electron‐demand Diels–Alder reactions …”
Section: Radiopharmaceutical Chelatesmentioning
confidence: 99%